{"count": 2, "results": [{"_id": "9695968", "pmid": 9695968, "title": "Inhibitory effect of simvastatin on the proliferation of human myeloid leukaemia cells in severe combined immunodeficient (SCID) mice.", "journal": "Br J Haematol", "authors": ["Clutterbuck RD", "Millar BC", "Powles RL", "Newman A", "Catovsky D", "Jarman M", "Millar JL"], "date": "1998-07-01T00:00:00Z", "doi": "10.1046/j.1365-2141.1998.00783.x", "meta_date_publication": "1998 Jul", "meta_volume": "102", "meta_issue": "2", "meta_pages": "522-7", "score": 50064.03, "text_hl": "Flow cytometric analysis of bone marrow and spleen cells confirmed these results by showing that @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ had reduced the percentage of @SPECIES_9606 @@@human@@@ @<m>DISEASE_Leukemia_T_Cell</m> @DISEASE_MESH:D015458 @@@leukaemia@@@ cells in these tissues by 70% and 88% respectively. ", "citations": {"NLM": "Clutterbuck RD, Millar BC, Powles RL, Newman A, Catovsky D, Jarman M, Millar JL. Inhibitory effect of simvastatin on the proliferation of human myeloid leukaemia cells in severe combined immunodeficient (SCID) mice. Br J Haematol. 1998 Jul;102(2):522-7. PMID: 9695968", "BibTeX": "@article{9695968, title={Inhibitory effect of simvastatin on the proliferation of human myeloid leukaemia cells in severe combined immunodeficient (SCID) mice.}, author={Clutterbuck RD and Millar BC and Powles RL and Newman A and Catovsky D and Jarman M and Millar JL}, journal={Br J Haematol}, volume={102}, number={2}, pages={522-7}}"}}, {"_id": "9086443", "pmid": 9086443, "title": "A comparison of the effect of the 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors simvastatin, lovastatin and pravastatin on leukaemic and normal bone marrow progenitors.", "journal": "Leuk Lymphoma", "authors": ["Newman A", "Clutterbuck RD", "Powles RL", "Catovsky D", "Millar JL"], "date": "1997-02-01T00:00:00Z", "doi": "10.3109/10428199709055590", "meta_date_publication": "1997 Feb", "meta_volume": "24", "meta_issue": "5-6", "meta_pages": "533-7", "score": 50052.426, "text_hl": "These results indicate that, in addition to @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@, @CHEMICAL_Lovastatin @CHEMICAL_MESH:D008148 @@@lovastatin@@@ and @CHEMICAL_Pravastatin @CHEMICAL_MESH:D017035 @@@pravastatin@@@ are also selective inhibitors of leukaemic cell growth, however @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ was chosen for clinical trial in @SPECIES_9606 @@@patients@@@ with @<m>DISEASE_Leukemia_T_Cell</m> @DISEASE_MESH:D015458 @@@leukaemia@@@.", "citations": {"NLM": "Newman A, Clutterbuck RD, Powles RL, Catovsky D, Millar JL. A comparison of the effect of the 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors simvastatin, lovastatin and pravastatin on leukaemic and normal bone marrow progenitors. Leuk Lymphoma. 1997 Feb;24(5-6):533-7. PMID: 9086443", "BibTeX": "@article{9086443, title={A comparison of the effect of the 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors simvastatin, lovastatin and pravastatin on leukaemic and normal bone marrow progenitors.}, author={Newman A and Clutterbuck RD and Powles RL and Catovsky D and Millar JL}, journal={Leuk Lymphoma}, volume={24}, number={5-6}, pages={533-7}}"}}]}